The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial).

Poordad F, Rustgi V, Brown RS Jr, Patel V, Kugelmas M, Regenstein F, Balart L, LaBrecque D, Brown K, Avila M, Biederman M, Freed G, Smith R, Bernstein M, Arnold H, Cahan J, Fink S, Katkov W, Massoumi H, Harrison S

Open source

DOI: 10.1177/1756283x15588876
Published: 2015 Sep
Container: Therapeutic advances in gastroenterology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/1756283x15588876,
  title = {The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial).},
  author = {Poordad F and Rustgi V and Brown RS Jr and Patel V and Kugelmas M and Regenstein F and Balart L and LaBrecque D and Brown K and Avila M and Biederman M and Freed G and Smith R and Bernstein M and Arnold H and Cahan J and Fink S and Katkov W and Massoumi H and Harrison S},
  year = {2015},
  journal = {Therapeutic advances in gastroenterology},
  doi = {10.1177/1756283x15588876},
  url = {https://doi.org/10.1177/1756283x15588876}
}

RIS

TY  - JOUR
TI  - The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial).
AU  - Poordad F
AU  - Rustgi V
AU  - Brown RS Jr
AU  - Patel V
AU  - Kugelmas M
AU  - Regenstein F
AU  - Balart L
AU  - LaBrecque D
AU  - Brown K
AU  - Avila M
AU  - Biederman M
AU  - Freed G
AU  - Smith R
AU  - Bernstein M
AU  - Arnold H
AU  - Cahan J
AU  - Fink S
AU  - Katkov W
AU  - Massoumi H
AU  - Harrison S
PY  - 2015
JO  - Therapeutic advances in gastroenterology
DO  - 10.1177/1756283x15588876
UR  - https://doi.org/10.1177/1756283x15588876
ER  -

APA

F, P., V, R., Jr, B. R., V, P., M, K., F, R., L, B., D, L., K, B., M, A., M, B., G, F., R, S., M, B., H, A., J, C., S, F., W, K., H, M., & S, H. (2015). The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial).. Therapeutic advances in gastroenterology. https://doi.org/10.1177/1756283x15588876

Source records

pubmed · retrieved 2026-09-25T22:02:01.910Z